{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:12:48Z","timestamp":1782997968340,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006724","name":"Japanese Urological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008879","name":"Japanese Foundation for Prostate Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["14207061"],"award-info":[{"award-number":["14207061"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16591582"],"award-info":[{"award-number":["16591582"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16689026"],"award-info":[{"award-number":["16689026"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["17791006"],"award-info":[{"award-number":["17791006"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.eururo.2006.08.047","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T07:16:35Z","timestamp":1158131795000},"page":"375-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The Clinical Potential of Pretreatment Serum Testosterone Level to Improve the Efficiency of Prostate Cancer Screening"],"prefix":"10.1016","volume":"51","author":[{"given":"Masashi","family":"Yano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Imamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.08.047_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/scbi.1998.0075","article-title":"What causes prostate cancer? A brief summary of the epidemiology","volume":"8","author":"Chan","year":"1998","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.eururo.2006.08.047_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000019910","article-title":"Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts","volume":"35","author":"Ekman","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnci\/88.16.1118","article-title":"Prospective study of sex hormone levels and risk of prostate cancer","volume":"88","author":"Gann","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2006.08.047_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<312::AID-CNCR15>3.0.CO;2-7","article-title":"Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma","volume":"86","author":"Ritva","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2006.08.047_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-4295(00)00637-3","article-title":"Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging","volume":"56","author":"Catalona","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.08.047_bib6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(20000815)89:4<842::AID-CNCR17>3.0.CO;2-9","article-title":"Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma","volume":"89","author":"Kikuchi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2006.08.047_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0022-5347(05)67080-2","article-title":"Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer","volume":"164","author":"Brawer","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0090-4295(00)00613-0","article-title":"Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer","volume":"56","author":"Ito","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.08.047_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archsurg.1941.01210140043004","article-title":"Studies on prostatic cancer: II. The effect of castration on advanced carcinoma of the prostate gland","volume":"43","author":"Huggins","year":"1941","journal-title":"Arch Surg"},{"key":"10.1016\/j.eururo.2006.08.047_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.2000.18.4.847","article-title":"Hormonal predictors of prostate cancer: a meta-analysis [related articles]","volume":"18","author":"Shaneyfelt","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2006.08.047_bib11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0022-5347(17)41193-1","article-title":"Prognostic factors in survival free progression after androgen deprivation therapy for treatment of prostate cancer","volume":"141","author":"Ishikawa","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00000421-199712000-00015","article-title":"Low testosterone and a younger age predict a poor outcome in metastatic prostate cancer","volume":"20","author":"Ribeiro","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.eururo.2006.08.047_bib13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-5347(05)67812-3","article-title":"Is low serum free testosterone a marker for high grade prostate cancer?","volume":"163","author":"Hoffmann","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/01.ju.0000062674.43964.d0","article-title":"Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy","volume":"169","author":"Massengill","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib15","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.eururo.2004.11.003","article-title":"Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy","volume":"47","author":"Imamoto","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0045(20000801)44:3<219::AID-PROS6>3.0.CO;2-I","article-title":"Endocrine patterns in patients with benign and malignant prostatic disease","volume":"44","author":"Schatzl","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2006.08.047_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2006.08.047_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0022-5347(01)62922-7","article-title":"Influence of radical prostatectomy on serum hormone levels","volume":"160","author":"Miller","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.08.047_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pros.10140","article-title":"Association between prostate cancer and serum testosterone levels","volume":"53","author":"Zhang","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2006.08.047_bib20","first-page":"4855","article-title":"Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor","volume":"53","author":"Lokeshwar","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2006.08.047_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.0.1490093","article-title":"Inhibin-related proteins in rat prostate","volume":"149","author":"Risbridger","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1016\/j.eururo.2006.08.047_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0024-3205(96)00664-9","article-title":"Expression and localization of inhibin\/activin subunits and activin receptors in the normal rat prostate","volume":"60","author":"Ying","year":"1997","journal-title":"Life Sci"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806010177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806010177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:01:05Z","timestamp":1759582865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806010177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0302283806010177"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.08.047","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Potential of Pretreatment Serum Testosterone Level to Improve the Efficiency of Prostate Cancer Screening","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2006.08.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}